CORALVILLE, Iowa--(BUSINESS WIRE)--Bolstering its commitment to providing researchers with powerful tools to discover more about biology and advance medicine, global genomics solutions provider ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Synthego, the genome engineering company, today announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by ...
FRANKFURT, GERMANY, December 11, 2024 /EINPresswire.com/ -- Vivlion GmbH, a leader in CRISPR-based screening technologies, today announced the launch of its new ...
Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by ...
Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark Age predecessors, living until ripe old age and enjoying the fruits of our ...
Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to $3 million. CRISPR Therapeutics, Editas Medicine, Precision BioSciences ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...
CRISPR Therapeutics now has an approved product in its portfolio in Casgevy. The treatment has the potential to be a game changer for the company's business. Even with more treatments in its portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback